PIM1 and cancer: From the results, we also observed that Pyrimethamine exhibited stronger antiparasitic activity, while AZD1208 also showed a significant antiparasitic effect, leading us to believe that PIM1 still holds potential as a drug target against T. gondii, considering its role in cancer, the authors believe that, especially for some cancer patients, PIM1 inhibitors are a better option.